Advances in the role and mechanism of miRNA in inflammatory pain

Biomed Pharmacother. 2023 May:161:114463. doi: 10.1016/j.biopha.2023.114463. Epub 2023 Mar 1.

Abstract

Pain is a distressing experience associated with tissue damage or potential tissue damage, and its occurrence is related to sensory, emotional, cognitive and social factors. Inflammatory pain is one of the chronic pains where pain hypersensitivity are functional features of inflammation used to protect tissues from further damage. Pain has a serious impact on people's lives and has become a social problem that cannot be ignored. MiRNAs are small non-coding RNA molecules that exert directing effects on RNA silencing by complementary binding to the 3'UTR of target mRNA. MiRNAs can target a number of protein-coding genes and participate in almost all developmental and pathological processes in animals. Growing studies have suggested that miRNAs have significant implications for inflammatory pain via participating in multiple processes during the occurrence and development, such as affecting the activation of glial cells, regulating pro-inflammatory cytokines and inhibiting central and peripheral sensitization. In this review, the advances in the role of miRNAs in inflammatory pain were discussed. miRNAs as a class of micro-mediators are potential biomarkers and therapeutic targets for inflammatory pain, which provides a better diagnostic and treatment approach for inflammatory pain.

Keywords: Glial cells; Inflammatory pain; Mechanism; mRNA; miRNA.

Publication types

  • Review

MeSH terms

  • Animals
  • Cytokines / metabolism
  • MicroRNAs* / genetics
  • MicroRNAs* / metabolism
  • Neuroglia / metabolism
  • Pain / genetics
  • RNA, Messenger

Substances

  • MicroRNAs
  • Cytokines
  • RNA, Messenger